Tessera Therapeutics Presents New Data Demonstrating the : v

RNA Gene Writing™ platform demonstrates continued advances in rewriting to correct pathogenic mutations responsible for phenylketonuria (PKU), alpha-1...

Related Keywords

California , United States , American , Los Angeles , Michael Holmes , Michael Severino , Anne Shelton , American Society Of Gene , Lifesci Communications , Cecilia Cotta Ramusino , Gene Writing , American Society , Cell Therapy , Annual Meeting , Chief Scientific Officer , Gene Writers , Genome Engineering , Target Primed Reverse , Writers Efficiently Make True Corrections , Causative Mutations , Multiple Models , Robust Antitumor , Writer Corrects Severe Ornithine Transcarbamylase , Gene Writer , Flagship Pioneering , Sci Communications , Tessera Therapeutics ,